Nektar(美國)

Nektar Therapeutics

美國NektarTherapeuticswww.nektar.comNektarTherapeuticsisabiopharmaceuticalcompanydevelopingnoveltherapeuticsbasedonitsPEGylationandadvancedpolymerconjugationtechnologyplatforms.NektarhasarobustR&Dpi pelineofpotentiallyhigh-valuetherapeuticsinoncology,painandothertherapeuticareas.Intheareaofpain,NektarhasanexclusiveworldwidelicenseagreementwithAstraZenecaforNKTR-118,aninvestigationaldrugcandidate,whichisbeingevaluatedinPhase3clinicalstudiesasaonce-daily,oraltabletforthetreatmentofopioid-inducedconstipation.ThislicenseagreementalsoincludesNKTR-119,anearlierstagedevelopmentprogramthatisaco-formulationofNKTR-118andanopioid.NKTR-181,anovelmu-opioidanalgesic,hascompletedPhase1developmentandisbeingpreparedforaPhase2study.NKTR-102isbeingevaluatedinaPhase3clinicalstudyforthetreatmentofmetastaticbreastcancerandinPhase2studiesforth